AVR Earnings Date: Nov 11, 2026 (Estimated) — Anteris Technologies Global Corp.
NASDAQ · Healthcare · Medical Instruments & Supplies
Updated
When is AVR's next earnings date?
Anteris Technologies Global Corp. (AVR) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 6:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.31 on revenue of $2.8M.
How did AVR do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Anteris Technologies Global Corp. posted EPS of -$0.30 versus the -$0.21 estimate, a miss of 42.9%. Revenue was $1.0M against a $1.5M estimate. The stock's 1-day post-earnings move was -3.3%.
How much does AVR stock move after earnings?
AVR beat EPS estimates in 0 of its last 5 reported quarters. Over the last 5 reports the stock moved an average of 3.4% (up or down) in the day after earnings.
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.21 | -0.30 | -42.86% | $1.0M | ❌ Miss | -3.27% | +4.47% | -9.49% |
| 2026-05-12 | Q1 2026 | -0.27 | -0.28 | -3.70% | $494,000 | ❌ Miss | -2.54% | +14.93% | +38.96% |
| 2026-02-26 | Q4 2025 | -0.56 | -0.75 | -33.93% | $310,000 | ❌ Miss | +2.68% | -0.16% | -18.14% |
| 2025-11-12 | Q3 2025 | -0.57 | -0.62 | -8.77% | $429,000 | ❌ Miss | -2.57% | -12.60% | +28.02% |
| 2025-08-11 | Q2 2025 | -0.53 | -0.58 | -9.43% | $618,000 | ❌ Miss | +6.00% | +8.57% | +37.71% |
Showing last 5 quarters.
Revenue by segment & region
By region
Q2 FY26 · $1.0M total
| Segment | Share | Revenue | YoY | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 98.6% | $995K | +63.1% | $610K | $420K | $301K | $484K |
| AUSTRALIA | 1.4% | $14K | +75.0% | $8K | $9K | $8K | $10K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.